Cannabis
At 4.6% CAGR, Global Encapsulated Flavors and Fragrances Market Size to Hit USD 4.89 Billion Mark by 2028: Industry Trends, Share & Forecast by Facts & Factors
NEW YORK, USA, Feb. 28, 2022 (GLOBE NEWSWIRE) — Facts and Factors has published a new research report titled “Encapsulated Flavors and Fragrances Market – By Form (Macro-encapsulated, Microencapsulated, and others), By End-user (Food & Beverages, Cleaners, Toiletries, Personal Care & Cosmetics, and Others) and By Product Category (Essential Oils & Natural Extracts, Aroma Chemicals, Flavor Blends, and Fragrance Blends): Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecast 2021–2028” in its research database.
“According to the latest research study, the demand of global Encapsulated Flavors and Fragrances Market size & share was valued at approximately USD 3.27 Billion in 2020 and is expected to grow a value of around USD 4.89 Billion by 2028, at a compound annual growth rate (CAGR) of about 4.6% during the forecast period 2021 to 2028.”
What are Encapsulated Flavors and Fragrances? How big is the Encapsulated Flavors and Fragrances Market?
Market Overview:
Encapsulation is a methodology of containing flavors and fragrances by using a coating material. Encapsulation isolates the coated material for the external environment. This precludes the loss of fragrances and flavor and restraints the deterioration throughout processing and storage. Moreover, this methodology offers functional properties to flavor and fragrance such as the controlled release of flavor and fragrance molecules as per the requirement of different environments including spray, water, and mouth, in products for example candy, food coloring, toothpaste, flavored tea, and others. The market is anticipated to bolster at a CAGR of 4.5% throughout the forecast period.
Click Here To Access Free Sample Report of the Global Encapsulated Flavors and Fragrances Market @ https://www.fnfresearch.com/sample/encapsulated-fragrances-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2021 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 210+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2021
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Market Growth Dynamics
The fast-paced life, changing lifestyle, and changing food habits are increasing the demand for packaged food & beverages. This is supporting the rising demand for encapsulated flavors and fragrances resulting in the market’s growth globally.
Moreover, increasing investment by major players and rapid development in technologies accompanied by increased R&D investment is encouraging the encapsulated flavors and fragrances market growth. However, the higher cost of encapsulation technologies may hinder the market’s growth. The high cost of encapsulation technologies leads to an increased final cost of the product. Moreover, the lack of availability of food-grade materials is deterring the business size. Furthermore, stringent government regulations concerning consumer safety are anticipated to restrain the industry growth from 2020 to 2028. Nevertheless, the rising application of encapsulated flavors and fragrances in various end-use industries such as food & beverages, textile, and personal care products is likely to offer a lucrative opportunity for market growth.
There is a substantial application of encapsulated flavors and fragrances in packaged food & beverages owing to the increasing demand for packaged food. Further, the encapsulated flavors and fragrances are used in textile and personal care products. Consumers tend to spend more on personal care products due to the increasing affordability and preference to maintain a healthy lifestyle. Growing consumer products and the personal care industry globally, especially in Europe and the Asia Pacific region, is anticipated to propel the encapsulated flavors and fragrances market growth in the near future.
Major Market Players
- Premium Foods Co. Ltd.
- Firmenich SA
- Ingredion Incorporated
- Etosha Pan
- Sonarome
- Lycored
- BÜCHI Labortechnik AG
- Sensient
- Clextral
- Cargill
- MANE
- FONA International Inc.
- Glatt GmbH
- Tate & Lyle plc
- AVEKA
Key questions answered in this report:
- What is the size of the encapsulated flavors and fragrances market and what is its expected growth rate?
- What are the main driving factors propelling the encapsulated flavors and fragrances market forward?
- What are the leading companies in the encapsulated flavors and fragrances industry?
- What segments do the encapsulated flavors and fragrances market cover?
- How can I receive a free copy of the encapsulated flavors and fragrances market sample report and company profiles?
Key Offerings:
- Market Size, Share & Forecast by Revenue | 2021−2028
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis by Form, by End-user, by Product Category, and by Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/encapsulated-fragrances-market
Report Scope
| Report Attribute | Details |
| Market Size in 2020 | USD 3.27 Billion |
| Projected Market Size in 2028 | USD 4.89 Billion |
| CAGR Growth Rate | 4.6% CAGR |
| Base Year | 2020 |
| Forecast Years | 2021-2028 |
| Key Market Players | Premium Foods Co. Ltd., Firmenich SA, Ingredion Incorporated, Etosha Pan, Sonarome, Lycored, BÜCHI Labortechnik AG, Sensient, Clextral, Cargill, MANE, FONA International Inc., Glatt GmbH, Tate & Lyle plc, and AVEKA., among others |
| Key Segment | By Form, By End-user, By Product Category, and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Segmentation Analysis
The encapsulated flavors and fragrances market is segmented based on form, end-user, and product category.
On the basis of form segmentation, the market is classified into macro-encapsulated, microencapsulated, and others. The microencapsulated segment is anticipated to encompass a substantial share in the global encapsulated flavor industry owing to its unique functionalities i.e. targeted action, popularity in the pharmaceutical industry, and huge R&D investments in innovations of this segment.
In terms of end-user segmentation, the market is bifurcated into food & beverages, cleaners, toiletries, personal care & cosmetics, and others. The food & beverage segment held a significant market share. This segment is estimated to witness substantial growth in the forecast period, owing to the fast past life and alteration of eating habits amongst the population. Based on product category, the market is divided into essential oils & natural extracts, aroma chemicals, flavor blends, and fragrance blends. Amongst all, aroma chemicals held the largest share globally.
Request for Customization on this Report as per your requirements – https://www.fnfresearch.com/customization/encapsulated-fragrances-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: [email protected]
Regional Dominance:
Geographically, Asia Pacific held the largest share for the global encapsulated flavors and fragrances market with an estimated market share of 42% in 2019, and it is anticipated to continue bolstering throughout the forecast period with a CAGR of approximately 4.5% by 2028.
This growth is owed to massive industrialization, rising per capita income, and prompt development in the pharmaceutical industry. Moreover, increasing the inclination of the population towards acquiring cosmetics products is also fueling the growth of this market in APAC. Japan is one of the world’s most technologically advanced countries. In Japan, healthy beverages are in high demand. To improve the consumer experience, encapsulated flavors and fragrances are used. Furthermore, the demand for encapsulated consumer goods with extended shelf life, such as laundry detergents, household care products, and others, is exceeding global demand.
Customers of all ages are getting increasingly interested in functional food products in China. Factors such as busy schedules, increasing disposable incomes, and increased awareness of healthy dietary requirements are driving demand for functional food items in China. Controlling the release of flavors through encapsulation is a useful method. As a result, the country’s businesses are heavily investing in this technology.
Recent Development
- In Oct 2020, the International Flavors & Fragrances (IFF), based in the United States, has launched a new innovation center in Dubai, United Arab Emirates, for its Taste business. Snacks, savory, sweet, dairy, and beverage makers will benefit from the new lab’s invention and application capabilities, according to the business. IFF hopes to address the demands of its customers in Africa, the Middle East, Turkey, and India by constructing a new LEED-certified plant in Dubai.
Browse the full “Encapsulated Flavors And Fragrances Market – By Form (Macro-encapsulated, Microencapsulated, and others), By End-user (Food & Beverages, Cleaners, Toiletries, Personal Care & Cosmetics, and Others) and By Product Category (Essential Oils & Natural Extracts, Aroma Chemicals, Flavor Blends, and Fragrance Blends): Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecast 2021–2028” report at https://www.fnfresearch.com/encapsulated-fragrances-market
This report segments the encapsulated flavors and fragrances market as follows:
By Form Segmentation Analysis
- Macro-encapsulated
- Microencapsulated
- Others
By End-user Segmentation Analysis
- Food & Beverages
- Cleaners
- Toiletries
- Personal Care & Cosmetics
- Others
By Product Category Segmentation Analysis
- Essential Oils & Natural Extracts
- Aroma Chemicals
- Flavor Blends
- Fragrance Blends
Key Insights & Findings from the report:
- As per the analysis shared by our primary respondents, the Encapsulated Flavors and Fragrances market is expected to grow at a CAGR of around 4.6% by 2028.
- Through the primary research, it was established that the Encapsulated Flavors and Fragrances market was valued at around USD 3.27 Billion in 2020 and is projected to generate around USD 4.89 Billion by 2028.
- In terms of end-user segmentation, the food & beverage segment held a high market share and is expected to rise substantially over the projection period.
- On the basis of region, the Asia Pacific dominated the global market and is expected to grow at a CAGR of 4.5 percent by 2028.
Spectacular Deals
- Comprehensive coverage
- Maximum tables and figures
- Subscription-based option offered
- Best price guaranteed
Do Inquiry for More info on the Global Encapsulated Flavors and Fragrances Market @ https://www.fnfresearch.com/inquiry/encapsulated-fragrances-market
Browse Other Related Research Reports from Facts & Factors
Flavors and Fragrance Market: https://www.fnfresearch.com/global-flavors-and-fragrance-market-by-product-type
Cannabis Infused Beauty Products Market: https://www.fnfresearch.com/global-cannabis-infused-beauty-products-market-by-product
Specialty Chemicals Market: https://www.fnfresearch.com/specialty-chemicals-market-by-type-specialty-polymers-industrial
Smart Kitchen Appliances Market: https://www.fnfresearch.com/smart-kitchen-appliances-market
Away from Home Hand Soaps and Sanitizer Market: https://www.fnfresearch.com/away-from-home-hand-soaps-and-sanitizer-market-1288
Artificial Intelligence in Retail Market: https://www.fnfresearch.com/artificial-intelligence-in-retail-market
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us on Twitter: https://twitter.com/fnfresearch
Follow Us on Facebook: https://www.facebook.com/factsandfactors/
Contact Us:
Sanu Thomas
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 96043 17127
Email: [email protected]
Web: https://www.fnfresearch.com
Blog: http://fnfnewsblog.com
TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ — IM Cannabis Corp. (“IMC” or the “Company“) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company’s board of directors (the “Board“) effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company’s commitment to driving growth while focusing on sustainable profitability.
“We are thrilled to welcome Shmulik to our Board of Directors,” said Oren Shuster, Chief Executive Officer of IM Cannabis. “Shmulik’s extensive international experience at Leumi, coupled with his proven track record in banking and finance will be invaluable as we continue to deliver on our strategic initiatives.”
Mr. Arbel retired as Deputy CEO from Leumi, Israel’s largest banking group, in April 2023, where he was instrumental in business growth and leading the service revolution. With over 25 years of experience at Leumi, Arbel has held senior roles throughout the organization, such as head of retail banking, head of the corporate division, and as chairman of Leumi UK. With key roles in Israel, New York and London, Mr. Arbel has a wide view on international business.
“I am honored to join the Board of Directors at IMCC,” said Mr. Arbel. “I look forward to leveraging my experience in banking and finance, providing guidance as IMCC continues to establish itself as the go-to brand in the cannabis world. I look forward to contributing to the company’s growth.”
Arbel holds a BA and MBA from Tel Aviv University.
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.
Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, “forward-looking statements“). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to: the stated benefits Mr. Arbel’s appointment, including the further strengthening the Company’s commitment to driving growth in the German market while focusing on sustainable profitability; and Mr. Arbel’s international experience and track record in banking and finance will be invaluable to the Company.
Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the Company’s ability to realize upon the stated benefits Mr. Arbel’s appointment; and Mr. Arbel’s international experience and track record in banking and finance becoming invaluable to the Company.
The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and its subsidiaries (collectively, the “Group“) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the Israel-Hamas war on the Company, its operations and the medical cannabis industry in Israel; risks associated with the Company focusing on the Israel and Germany markets; the inability of the Company to achieve sustainable profitability and/or increase shareholder value; the inability of the Company to actively manage costs and/or improve margins; the inability of the company to grow and/or maintain sales; the inability of the Company to meet its goals and/or strategic plans; the inability of the Company to reduce costs and/or maintain revenues; the Company’s inability to take advantage of the legalization of medicinal cannabis in Germany; and the Company’s inability to realize upon the stated benefits Mr. Arbel’s appointment; and Mr. Arbel’s international experience and track record in banking and finance not becoming valuable to the Company.
Please see the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report dated March 28, 2024, which is available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]
Oren Shuster, CEO
IM Cannabis Corp.
[email protected]
Logo: https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/im-cannabis-announces-appointment-of-shmulik-arbel-to-board-of-directors-302244961.html
Cannabis
Europe Medical Cannabis Market Forecast 2024-2032: Tilray, Aurora Cannabis, and GW Pharmaceuticals Dominate the Market Landscape
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) — The “Europe Medical Cannabis Oil Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2024-2032.” report has been added to ResearchAndMarkets.com’s offering.
The Europe Medical Cannabis Oil market is poised for significant growth, projected to escalate from US$ 0.91 billion in 2023 to US$ 2.40 billion by 2032, advancing at a CAGR of 12.08%. In this comprehensive research report, the market is analyzed by:
- Derivatives;
- Source;
- Application;
- Route of Administration;
- End-user;
- Distribution Channel; and
- Country.
Market Highlights Identified in the Report
- Progressive legalization across Europe is creating a favorable regulatory environment, enhancing market expansion for medical cannabis oil products.
- Germany leads the market with a robust infrastructure and supportive regulations, while other countries like the UK, Italy, and Spain show significant growth potential based on evolving regulatory landscapes and market dynamics.
- Key players such as Tilray, Aurora Cannabis Inc., and GW Pharmaceuticals dominate the market, emphasizing research, strategic partnerships, and innovation to maintain competitive edge amidst evolving industry dynamics.
The medical cannabis oil market has experienced substantial growth as legalization and acceptance of cannabis-based treatments expand globally. Cannabis oil, derived from the cannabis plant through extraction methods, contains cannabinoids such as THC and CBD, known for their therapeutic properties. Increasing recognition of cannabis oil’s potential in alleviating symptoms of various medical conditions, including chronic pain, epilepsy, and anxiety disorders, has driven its adoption in medical settings.
Governments in several countries are progressively legalizing medical cannabis, creating a conducive regulatory environment for market expansion. Additionally, growing consumer awareness about alternative and natural therapies has fueled the demand for cannabis oil products. The market is characterized by diverse product offerings, including full-spectrum and CBD-isolate oils, catering to different therapeutic needs and preferences.
Despite regulatory challenges and stigma associated with cannabis, the medical cannabis oil market continues to evolve, driven by ongoing research, favorable legislative changes, and shifting attitudes toward cannabis-based therapies in healthcare.
Regional Insights
Germany is likely to maintain its leadership position in the European medical cannabis oil market due to its established infrastructure, supportive regulations, and strong healthcare system. Germany legalized medical cannabis in 2017, giving the market a head start compared to many other European countries. This established infrastructure and experience position Germany as a leader in the field. As awareness and acceptance of medical cannabis increase, the number of patients seeking treatment in Germany is steadily rising. This fuels market growth and incentivizes further investment in research and development.
Germany’s regulatory framework for medical cannabis is considered relatively patient-friendly compared to some other European countries. This facilitates access for patients with qualifying conditions. The UK legalized medical cannabis in 2018 and is experiencing an increase in patient access programs. This, coupled with ongoing research, could lead to significant market growth. Italy legalized medical cannabis in 2006 but has faced challenges with availability. As regulations become more streamlined and patient access expands, the Italian market holds significant growth potential. Spain has a well-established medical cannabis industry with a focus on domestic production. As regulations evolve and export opportunities increase, the Spanish market could see a boost.
Competitive Landscape
The Medical Cannabis Oil market is characterized by a vigorous competitive landscape, with prominent entities like Tilray, Aurora Cannabis Inc., GW Pharmaceuticals, Almiral, Bedrocan, and others at the forefront, collectively accounting for approximately 41 % of the overall market share. This competitive milieu is fueled by their intensive efforts in research and development as well as strategic partnerships and collaborations, underscoring their commitment to solidifying market presence and diversifying their offerings.
The primary competitive factors include pricing, product caliber, and technological innovation. As the Medical Cannabis Oil industry continues to expand, the competitive fervor among these key players is anticipated to intensify. The impetus for ongoing innovation and alignment with evolving customer preferences and stringent regulations is high. The industry’s fluidity anticipates an uptick in novel innovations and strategic growth tactics from these leading corporations, which in turn propels the sector’s comprehensive growth and transformation.
Key Topics Covered
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 3. Executive Summary: Europe Medical Cannabis Oil Market
Chapter 4. Europe Medical Cannabis Oil Market Overview
Chapter 5. Europe Medical Cannabis Oil Market Analysis, by Derivatives
Chapter 6. Europe Medical Cannabis Oil Market Analysis, by Source
Chapter 7. Europe Medical Cannabis Oil Market Analysis, by Application
Chapter 8. Europe Medical Cannabis Oil Market Analysis, by Route of Administration
Chapter 9. Europe Medical Cannabis Oil Market Analysis, by End-user
Chapter 10. Europe Medical Cannabis Oil Market Analysis, by Distribution Channel
Chapter 11. Europe Medical Cannabis Oil Market Analysis, by Country
Chapter 12. The UK Medical Cannabis Oil Market Analysis
Chapter 13. Germany Medical Cannabis Oil Market Analysis
Chapter 14. The Netherlands Medical Cannabis Oil Market Analysis
Chapter 15. Italy Medical Cannabis Oil Market Analysis
Chapter 16. Spain Medical Cannabis Oil Market Analysis
Chapter 17. Poland Medical Cannabis Oil Market Analysis
Chapter 18. Rest of Europe Medical Cannabis Oil Market Analysis
Chapter 19. Company Profiles (Company Overview, Financial Matrix, Key Product Landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurora Cannabis Inc.
- Bedrocan
- Biocann
- BIOTA Biosciences LLC
- Cannamedical
- Mary Jane CBD
- Sanity Group GmbH
- Tilray
- Valcon Medical
For more information about this report visit https://www.researchandmarkets.com/r/dh7q46
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
